{"id":47184,"date":"2026-07-06T12:21:43","date_gmt":"2026-07-06T12:21:43","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/lenz-therapeutics-announces-launch-of-new-telehealth-prescribing-option-to-accelerate-patient-access-to-vizz-for-the-treatment-of-presbyopia\/"},"modified":"2026-07-06T12:21:43","modified_gmt":"2026-07-06T12:21:43","slug":"lenz-therapeutics-announces-launch-of-new-telehealth-prescribing-option-to-accelerate-patient-access-to-vizz-for-the-treatment-of-presbyopia","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/lenz-therapeutics-announces-launch-of-new-telehealth-prescribing-option-to-accelerate-patient-access-to-vizz-for-the-treatment-of-presbyopia\/","title":{"rendered":"LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ\u00ae for the Treatment of Presbyopia"},"content":{"rendered":"
\n

VIZZ is now available for those who qualify through a convenient telehealth platform in addition to existing access through eye care professionals<\/em><\/p>\n

Telehealth offers patients the convenience of an integrated online evaluation by independent licensed eye care providers, e-pharmacy prescription fulfillment and home delivery<\/em><\/p>\n

Launch of telehealth alongside a nationwide TV advertising campaign featuring brand spokesperson Sarah Jessica Parker is expected to expand consumer awareness, access, and adoption of VIZZ\u00ae<\/sup><\/em><\/p>\n

SAN DIEGO, July 06, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or \u201cLENZ\u201d or the \u201cCompany\u201d), a pharmaceutical company focused on the commercialization of VIZZ\u00ae<\/sup> (aceclidine ophthalmic solution) 1.44%, the first and only aceclidine-based eye drop for the treatment of presbyopia, today announced that VIZZ is now available through a convenient telehealth platform, providing the convenience of an integrated online evaluation by independent licensed eye care providers (\u201cECPs\u201d), epharmacy prescription fulfillment and home delivery.<\/p>\n

Accessible through VIZZ.com<\/a>, the integrated telehealth platform connects patients with an independent network of licensed eye care professionals who will evaluate patient telehealth eligibility based upon their medical history. Prescriptions will be automatically routed and fulfilled by LENZ\u2019s epharmacy partner providing a seamless and convenient consumer journey from product interest to home delivery. Launch of the telehealth channel will be promoted alongside the Company\u2019s \u2018Tired of Reading Glasses\u2018 campaign featuring brand spokesperson Sarah Jessica Parker through both a national television advertising campaign and digital direct-to-consumer strategy.<\/p>\n

\u201cAt this stage of our launch, our goal is to make accessing VIZZ as seamless as possible,\u201d said Eef Schimmelpennink, President and Chief Executive Officer of LENZ Therapeutics. \u201cVIZZ continues to deliver the real-world efficacy we expected, and a telehealth platform provides a convenient option for the majority of the 128 million Americans living with presbyopia who may not visit an eye doctor annually. Through the launch of this platform, we are removing a key hurdle to product access by providing consumers with a safe and convenient way to be evaluated by an independent licensed eye care professional online who can determine whether VIZZ may be appropriate for them. We believe the combination of introducing telehealth and our national television advertising campaign will help accelerate consumer awareness, access and adoption of VIZZ.\u201d<\/p>\n

About Presbyopia<\/strong><\/p>\n

Presbyopia is the inevitable loss of near vision associated with aging, impacting the daily lives of nearly all people over the age of 45. As people age, the crystalline lens in their eyes gradually hardens and becomes less able to change shape. This loss of elasticity of the lens reduces the ability of the lens to focus incoming light from near objects onto the retina. Adults over 50 years of age lose, on average, 1.5 lines of near vision every six years. Although the progression of presbyopia is gradual, presbyopes often experience an abrupt change in their daily life as the symptoms become more pronounced starting in their mid-40s, when reading glasses or other corrective aids are suddenly necessary to read text or conduct close-up work. Presbyopia is typically self-diagnosed and self-managed with over-the-counter reading glasses, or managed, after evaluation by an ECP, with prescription reading or bifocal glasses or multifocal contact lenses.<\/p>\n

About VIZZ<\/strong>\u00ae<\/sup> (aceclidine ophthalmic solution) 1.44%<\/strong><\/p>\n

VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. Aceclidine is the sole active ingredient in VIZZ and provides rapid and durable near vision improvement. VIZZ is preservative-free and provided in single-dose vials. VIZZ is a predominantly pupil selective miotic that interacts with the iris with minimal ciliary muscle stimulation. VIZZ causes contraction of the iris sphincter muscle, resulting in a pinhole effect that extends depth of focus to improve vision. For more information, please visit www.VIZZ.com<\/a>.<\/p>\n

VIZZ Indication and Important Safety Information<\/strong><\/p>\n

INDICATION<\/strong><\/p>\n

VIZZ (aceclidine ophthalmic solution) 1.44% is a prescription eye drop used to treat age-related blurry near vision (presbyopia) in adults.<\/p>\n

IMPORTANT SAFETY INFORMATION<\/strong><\/p>\n